Search
Search Results
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 8, 2017
- Subject(s):
- Abuse-Deterrent Formulations -- economics
Abuse-Deterrent Formulations -- statistics & numerical data
Analgesics, Opioid -- economics
Analgesics, Opioid -- therapeutic use
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- prevention & control
Prescription Drug Diversion -- statistics & numerical data
Comparative Effectiveness Research
Cost-Benefit Analysis
Delayed-Action Preparations -- economics
Delayed-Action Preparations -- therapeutic use
Drug Compounding -- economics
Drug Overdose -- mortality
Insurance Coverage -- economics
Insurance, Pharmaceutical Services -- economics
Opioid-Related Disorders -- epidemiology
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, October 4, 2018
- Subject(s):
- Androgen Antagonists -- therapeutic use
Prostatic Neoplasms -- drug therapy
Androgen Antagonists -- adverse effects
Cost-Benefit Analysis
Disease Progression
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, December 20, 2018
- Subject(s):
- Antibodies, Monoclonal -- therapeutic use
Asthma -- drug therapy
Inflammation -- drug therapy
Antibodies, Monoclonal -- adverse effects
Antibodies, Monoclonal -- economics
Biological Therapy
Cost-Benefit Analysis
Hypersensitivity -- drug therapy
Inflammation -- complications
Treatment Outcome
Humans
United States
- Publication:
- [New York] : Commonwealth Fund, [2003]
- Subject(s):
- Diabetes Mellitus -- economics
Diabetes Mellitus -- prevention & control
Cost-Benefit Analysis
Managed Care Programs -- economics
Minnesota
New York
HealthPartners.
Independent Health Association.
- Publication:
- [New York] : Commonwealth Fund, [2003]
- Subject(s):
- Drug Therapy -- economics
Venous Thrombosis -- drug therapy
Hypercholesterolemia -- drug therapy
Cost-Benefit Analysis
Organizational Case Studies
Michigan
Henry Ford Health System.
- Author(s):
- March, Artemis.
- Publication:
- [New York] : Commonwealth Fund, [2003]
- Subject(s):
- Tobacco Use Cessation -- economics
Cost-Benefit Analysis
Program Development -- economics
Smoking -- economics
Organizational Case Studies
Washington
- Author(s):
- Spetz, Joanne, author
- Publication:
- [Oakland, Calif.] : California Health Care Foundation, September 2018
- Subject(s):
- Health Workforce -- statistics & numerical data
Nurse Practitioners -- statistics & numerical data
Nurse's Role
Quality of Health Care
Cost-Benefit Analysis
Government Regulation
Health Services Accessibility
Nurse Practitioners -- education
Primary Health Care
State Government
Humans
California
United States
- Author(s):
- Ollendorf, Daniel A., author
Ollendorf, Daniel A., author
Tarlochan Sandhu, Alexander, author
Chapman, Rick, author
Heidenreich, Paul A., author
Russo, Elizabeth, author
Shore, Karen K., author
Synnott, Patricia, author
Travers, Karin, author
Weissberg, Jed, author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, December 1, 2015
- Subject(s):
- Angiotensin II Type 1 Receptor Blockers -- administration & dosage
Antihypertensive Agents -- administration & dosage
Blood Pressure Monitoring, Ambulatory -- instrumentation
Blood Pressure Monitoring, Ambulatory -- methods
Heart Failure -- diagnosis
Heart Failure -- drug therapy
Neprilysin -- administration & dosage
Tetrazoles -- administration & dosage
Valsartan -- administration & dosage
Angiotensin II Type 1 Receptor Blockers -- economics
Antihypertensive Agents -- economics
Cost-Benefit Analysis
Drug Combinations
Drug Costs
Neprilysin -- antagonists & inhibitors
Neprilysin -- economics
Outcome and Process Assessment (Health Care)
Tetrazoles -- economics
Valsartan -- economics
Humans
United States
- Publication:
- Los Angeles, Calif. : UCLA Center for Health Policy Research, March 2011
- Subject(s):
- Community Health Services -- economics
Developmental Disabilities -- prevention & control
Health Care Rationing -- trends
Age Factors
Budgets
Cost-Benefit Analysis
Developmental Disabilities -- epidemiology
Efficiency, Organizational
Eligibility Determination
Forecasting
Health Care Costs -- trends
Health Expenditures
Health Services Accessibility
Quality of Health Care
Rate Setting and Review
State Government
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 23, 2018
- Subject(s):
- Immunotherapy, Adoptive
Leukemia, B-Cell -- drug therapy
Lymphoma, B-Cell -- drug therapy
Lymphoma, Non-Hodgkin -- drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
Adult
Child
Clinical Trials as Topic
Clofarabine -- therapeutic use
Cost-Benefit Analysis
Immunotherapy, Adoptive -- adverse effects
Immunotherapy, Adoptive -- economics
Receptors, Chimeric Antigen -- therapeutic use
Treatment Outcome
Humans
United States
